Researchers from the University of Pennsylvania have devised a biomarker panel that could enable earlier diagnosis and better treatment for patients with pancreatic cancer, according to a study published in Science Translational Medicine.
Pancreatic cancer is the fourth leading cause of cancer death in the U.S., the team reported, and often patients are not diagnosed until an advanced stage. At that point, their tumors can’t be removed surgically.
Get the full story at our sister site, Drug Delivery Business News.